Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells
- PMID: 17320820
- DOI: 10.1016/j.bbrc.2007.02.041
Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells
Abstract
Signaling via the type 1 insulin-like growth factor receptor (IGF1R) confers resistance to EGF receptor (EGFR) inhibitors. It is plausible that reciprocal EGFR compensation could mediate resistance to IGF1R inhibition, prompting us to investigate effects of IGF1R depletion on EGFR signaling in breast cancer cells expressing relatively high (MDA-MB-468) or low (MCF7) EGFR. Transient IGF1R knockdown induced enhanced phosphorylation of the EGFR and its effectors JNK, ERKs and STAT5, but this did not prevent apoptosis induction and inhibition of clonogenic survival following IGF1R knockdown. We used IGF1R shRNA to induce chronic IGF1R depletion, and achieved stable gene silencing in MCF-7 cells; here, EGFR overexpression led to EGFR hyperphosphorylation, again without abrogating survival inhibition after IGF1R knockdown. In both cell lines, dual receptor knockdown prevented EGFR hyperphosphorylation, but induced no greater inhibition of clonogenic survival than IGF1R knockdown alone. These results suggest that the EGFR cannot compensate for IGF1R depletion, and are encouraging for the strategy of IGF1R targeting.
Similar articles
-
The EGF receptor interacts with the type 1 IGF receptor and regulates its stability.Biochem Biophys Res Commun. 2007 Apr 13;355(3):707-14. doi: 10.1016/j.bbrc.2007.02.012. Epub 2007 Feb 9. Biochem Biophys Res Commun. 2007. PMID: 17307140
-
Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.J Laryngol Otol. 2008 Sep;122(9):952-60. doi: 10.1017/S0022215107000606. Epub 2007 Oct 2. J Laryngol Otol. 2008. PMID: 17908353
-
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.Cancer Res. 2007 Jan 1;67(1):391-7. doi: 10.1158/0008-5472.CAN-06-1712. Cancer Res. 2007. PMID: 17210722
-
Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.Steroids. 2009 Jul;74(7):586-94. doi: 10.1016/j.steroids.2008.11.020. Epub 2008 Dec 7. Steroids. 2009. PMID: 19138696 Review.
-
Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.Nat Clin Pract Oncol. 2007 Oct;4(10):591-602. doi: 10.1038/ncponc0934. Nat Clin Pract Oncol. 2007. PMID: 17898809 Review.
Cited by
-
Phosphoproteomic screen identifies potential therapeutic targets in melanoma.Mol Cancer Res. 2011 Jun;9(6):801-12. doi: 10.1158/1541-7786.MCR-10-0512. Epub 2011 Apr 26. Mol Cancer Res. 2011. PMID: 21521745 Free PMC article.
-
Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.J Clin Oncol. 2010 Nov 20;28(33):4985-95. doi: 10.1200/JCO.2009.27.5040. Epub 2010 Oct 25. J Clin Oncol. 2010. PMID: 20975071 Free PMC article. Review.
-
Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression.J Virol. 2015 Nov;89(21):10774-85. doi: 10.1128/JVI.01463-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269183 Free PMC article.
-
Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.Cancer Res. 2008 May 1;68(9):3314-22. doi: 10.1158/0008-5472.CAN-08-0132. Cancer Res. 2008. PMID: 18451158 Free PMC article.
-
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.Breast Cancer Res. 2008;10(4):R56. doi: 10.1186/bcr2113. Epub 2008 Jul 8. Breast Cancer Res. 2008. PMID: 18611244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous